Tag

NASDAQ: IONS

GSK wins FDA approval for Hibsago in chronic hepatitis B
Adrian Kessler · Oct 21, 2026
BioCryst Pharmaceuticals wins FDA approval for 150 mg ORLADEYO pellets
Adrian Kessler · Oct 21, 2026
Ionis Pharmaceuticals' Phase 3 kidney trial meets proteinuria endpoint
Adrian Kessler · Sep 23, 2026